Stock Events

Stock Events

Search...

Alnylam Pharmaceuticals (ALNY) Q3 2024 Earnings

1AugConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

-1.32

-0.3

0.72

1.74

Details

Expected EPS

-1.067018

Actual EPS

-0.13

Surprise EPS

0.94

Surprise Percent

+87.82%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.13 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.